View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Fulcrum Therapeutics to Participate in Upcoming December Conferences

Fulcrum Therapeutics to Participate in Upcoming December Conferences CAMBRIDGE, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in the following conferences: Piper Sandler 36th Annual Healthcare ConferenceDecember 3, 2024Fireside Chat at 12:00 pm ET, Participation link: New York, New York Citi 2024 Global Healthcare ConferenceDecember ...

 PRESS RELEASE

Greenwich LifeSciences Partners with GIM in Italy

Greenwich LifeSciences Partners with GIM in Italy STAFFORD, Texas, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced its partnership with clinical sites in Italy. The Company has partnered with "Gruppo Italiano Mammella" (GIM), the largest academic cooperative breast cancer research group in Italy, including over 150 participating centers and approx...

 PRESS RELEASE

Greenwich LifeSciences Provides Update on Corporate Events

Greenwich LifeSciences Provides Update on Corporate Events STAFFORD, Texas, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following update on corporate events. The Company's 2024 events to date are listed below: Feb 29 - Mar 1, 2024 – GBG Annual Scientific Meeting (German clinical network conference)Jun 1 - 4, 2024 – American Society o...

PNC Financial Services Group Inc: 2 directors

A director at PNC Financial Services Group Inc sold 30,000 shares at 210.086USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...

 PRESS RELEASE

Fulcrum Therapeutics Announces Recent Business Highlights and Financia...

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2024 ― Patient enrollment and site activation progressing in Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ― ― Ended the third quarter of 2024 with $257.2 million in cash, cash equivalents, and marketable securities; cash runway into at least 2027 ― ― Conference call and webcast scheduled for 8:00 a.m. ET today ― CAMBRIDGE, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on ...

 PRESS RELEASE

Fulcrum Therapeutics to Participate in the Stifel Healthcare Conferenc...

Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in a fireside chat at the Stifel Healthcare Conference in New York City on November 19th at 3:35 pm ET. Management will also participate in one-on-one investor meetings. The webcast of the fireside chat will ...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: November 9, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Appian Announces Third Quarter 2024 Financial Results

Appian Announces Third Quarter 2024 Financial Results Third quarter cloud subscription revenue increased 22% year-over-year to $94.1 million MCLEAN, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) today announced financial results for the third quarter ended September 30, 2024. “Appian continues to grow even as we become more efficient. Growth remains our top priority. We now project positive adjusted EBITDA for the full year 2024,” said Matt Calkins, CEO & Founder. Third Quarter 2024 Financial Highlights: Revenue: Cloud subscription revenue was $94.1 million, up 22% com...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: November 6, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conf...

Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:00 a.m. ET CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its third quarter 2024 financial results will be released on Wednesday, November 13, 2024, before the U.S. financial markets open. Management will host a conference c...

 PRESS RELEASE

Atlassian Announces First Quarter Fiscal Year 2025 Results

TEAM, Anywhere/SAN FRANCISCO--(BUSINESS WIRE)-- Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, today announced financial results for its first quarter ended September 30, 2024. A shareholder letter was posted on Atlassian’s Work Life blog at and in the Investor Relations section of Atlassian’s website at . First Quarter Fiscal Year 2025 Earnings Results “Through the power of our R&D engine, we’re not just marketing AI, we’re shipping it. I’m thrilled our team was able to launch Rovo, our latest product built for the AI era, into gen...

PNC Financial Services Group, Inc.: Solid earnings as net interest mar...

PNC reported solid earnings in Q3, with net interest income and net interest margin increasing; asset quality weakened modestly but remains solid.

 PRESS RELEASE

Appian To Announce Third Quarter 2024 Financial Results on November 7,...

Appian To Announce Third Quarter 2024 Financial Results on November 7, 2024 MCLEAN, Va., Oct. 09, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: APPN) today announced that it will release financial results for the third quarter ended September 30, 2024, before the U.S. financial markets open on Thursday, November 7, 2024. The company will host a conference call and live webcast to review its financial results and business outlook. Conference Call Details The conference call will begin at 8:30 a.m. Eastern Time. To access the call, please use this . Once registered, participants can join the call, u...

 PRESS RELEASE

Atlassian Announces Date for First Quarter of Fiscal Year 2025 Financi...

TEAM, Anywhere/SAN FRANCISCO--(BUSINESS WIRE)-- Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, today announced that it will release financial results for its first quarter of fiscal year 2025 ended September 30, 2024 after market close on Thursday, October 31, 2024. Atlassian will host a conference call to discuss the financial results at 2:00 P.M. Pacific Time. In conjunction with its earnings press release, Atlassian will post a shareholder letter to the Investor Relations section of its website at . Webcast Details When: Thursday...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: October 3, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

PNC Financial Services Group, Inc.: Update to credit analysis followin...

Our credit view of this issuer reflects its status as a strong and diverse deposit franchise and its solid credit risk management, constrained by the context of its high ratings.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: September 25, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Moody's Ratings affirms PNC's ratings (long-term senior unsecured A3);...

Moody's Ratings (Moody's) has affirmed all of the ratings and assessments of PNC Financial Services Group, Inc. and those of its subsidiaries (collectively referred to as PNC). The parent company is rated A3 for senior unsecured debt. Its bank subsidiary, PNC Bank, N.A., has an a2 Baseline Credit As...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch